Cardinal Health Inc.
Cardinal Health Appoints New Independent Director
Summary
Cardinal Health, Inc. announced on February 28, 2024, that Robert 'Bob' Azelby has been elected to its Board of Directors, effective March 1, 2024. Mr. Azelby, a seasoned healthcare industry leader with over 30 years of experience, notably as CEO of Eliem Therapeutics, brings extensive expertise in biopharmaceutical and oncology sectors. His appointment was disclosed via a press release furnished as Exhibit 99.1.
Profitelligence Alerts
Get alerts for CAH
Be first to know when Cardinal Health Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Cardinal Health Inc.
Cardinal Health Inc. is a major global healthcare services and products company, distinguished for providing end-to-end medical solutions. Specializing in healthcare distribution and supply chain management, Cardinal Health serves a comprehensive array of clients including hospitals, pharmacies, and healthcare providers. Notably, the company distributes pharmaceuticals, medical products, and laboratory supplies, ensuring efficient delivery to improve healthcare outcomes. Based in Dublin, Ohio, Cardinal Health plays a pivotal role in enhancing healthcare operational efficiency, offering extensive services like inventory management, logistics optimization, and integrated healthcare solutions that empower providers to focus on patient care. As one of the largest pharmaceutical distributors in the United States, it holds substantial influence in the healthcare sector, pivotal in ensuring the availability of drugs and medical supplies across various platforms, contributing significantly to the healthcare infrastructure worldwide.
Official SEC Documents
Advertisement